ENDOLOGIX INC's ticker is and the CUSIP is 29266SAA4. A total of 17 filers reported holding ENDOLOGIX INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $1,446,000,000 | +7.0% | 1,500,000 | 0.0% | 0.02% | -7.7% |
| Q4 2016 | $1,352,000,000 | -6.6% | 1,500,000 | 0.0% | 0.03% | +18.2% |
| Q3 2016 | $1,447,000,000 | +4.8% | 1,500,000 | 0.0% | 0.02% | -26.7% |
| Q2 2016 | $1,381,000,000 | +25.4% | 1,500,000 | 0.0% | 0.03% | +50.0% |
| Q1 2016 | $1,101,000,000 | -9.8% | 1,500,000 | 0.0% | 0.02% | -4.8% |
| Q4 2015 | $1,220,000,000 | +36.5% | 1,500,000 | +50.0% | 0.02% | +16.7% |
| Q3 2015 | $894,000,000 | -7.5% | 1,000,000 | 0.0% | 0.02% | +5.9% |
| Q2 2015 | $967,000,000 | -3.5% | 1,000,000 | 0.0% | 0.02% | -19.0% |
| Q1 2015 | $1,002,000,000 | +2.0% | 1,000,000 | 0.0% | 0.02% | +23.5% |
| Q4 2014 | $982,000,000 | +9.0% | 1,000,000 | 0.0% | 0.02% | +6.2% |
| Q3 2014 | $901,000,000 | -10.0% | 1,000,000 | 0.0% | 0.02% | -20.0% |
| Q2 2014 | $1,001,000,000 | +5.0% | 1,000,000 | 0.0% | 0.02% | +11.1% |
| Q1 2014 | $953,000,000 | – | 1,000,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 8,750,000 | $8,850,000 | 1.56% |
| Mohican Financial Management, LLC | 4,000,000 | $4,063,000 | 1.11% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 2,500,000 | $2,538,000 | 0.32% |
| ARISTEIA CAPITAL, L.L.C. | 3,500,000 | $3,561,000 | 0.20% |
| CSS LLC/IL | 3,400,000 | $3,445,000 | 0.16% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 12,650,000 | $12,848,000 | 0.15% |
| Myriad Asset Management Ltd. | 500,000 | $503,000 | 0.13% |
| Verition Fund Management LLC | 500,000 | $510,000 | 0.09% |
| Polar Asset Management Partners Inc. | 2,000,000 | $2,045,000 | 0.09% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,150,000 | $3,158,000 | 0.08% |